NASDAQ:PRTA
Prothena Corporation plc Stock News
$20.04
-0.0600 (-0.299%)
At Close: May 24, 2024
Prothena (PRTA) Q3 Earnings and Revenues Miss Estimates
10:05pm, Thursday, 04'th Nov 2021
Prothena (PRTA) delivered earnings and revenue surprises of -5.33% and -0.64%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
7 A-Rated Healthcare Stocks to Buy for the Long Haul
11:26am, Monday, 01'st Nov 2021
It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. The post 7 A-Rated Healthcare Stocks to Buy for the Long Haul appear
VRTX vs. PRTA: Which Stock Is the Better Value Option?
12:59pm, Thursday, 28'th Oct 2021
VRTX vs. PRTA: Which Stock Is the Better Value Option?
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 01'st Oct 2021
DUBLIN, Ireland, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein d
Prothena Announces Executive Appointments
04:05pm, Friday, 01'st Oct 2021
Expanded roles support the continued transition to a fully integrated biotechnology company focused on rare peripheral amyloid and neurodegenerative diseases Expanded roles support the continued trans
VRTX vs. PRTA: Which Stock Should Value Investors Buy Now?
01:00pm, Thursday, 23'rd Sep 2021
VRTX vs. PRTA: Which Stock Is the Better Value Option?
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
09:13am, Saturday, 18'th Sep 2021
Promising drug candidates could lead to a best-in-class Alzheimer's treatment.
Here's Why Prothena (PRTA) is a Great Momentum Stock to Buy
01:24pm, Thursday, 09'th Sep 2021
Does Prothena (PRTA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 03'rd Sep 2021
DUBLIN, Ireland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein
Prothena to Participate in Upcoming September Healthcare Conferences
04:05pm, Wednesday, 01'st Sep 2021
DUBLIN, Ireland, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of investigational therapeutics built on protein dysre
Prothena CEO breaks down the biotech firm's clinical trial timeline for therapeutics
07:41pm, Tuesday, 24'th Aug 2021
Gene Kinney, the president and CEO of Prothena, explained on Tuesday's "Mad Money" where the biotechnology company's therapeutics stand across the development timeline.
Here is Why Prothena (PRTA) is Up More Than 155% in Three Months
01:09pm, Friday, 13'th Aug 2021
Prothena (PRTA) surges substantially in the past three months on solid prospects of its AD candidates following Biogen???s AD drug approval.
Prothena (PRTA) Q2 Earnings Top Estimates
07:01pm, Thursday, 05'th Aug 2021
Prothena (PRTA) delivered earnings and revenue surprises of 1.75% and -0.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Prothena Corp Q2 Earnings
04:30pm, Thursday, 05'th Aug 2021
Shares of Prothena Corp (NASDAQ:PRTA) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 187.88% year over year to $0.58, which beat the e
Prothena to Report Second Quarter 2021 Financial Results on August 5th
04:05pm, Thursday, 29'th Jul 2021
DUBLIN, Ireland, July 29, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein d
